Ketamine inhibits transcription factors activator protein 1 and nuclear factor-κB, interleukin-8 production, as well as CD11b and CD16 expression: Studies in human leukocytes and leukocytic cell lines

Anesthesia and Analgesia

Volumn 110, Issue 3, 2010, Pages 934-941

  Welters, Ingeborg D ^a,b   Hafer, Georg ^b   Menzebach, Axel ^c   Mühling, Jörg ^b   Neuhäuser, Christoph ^b   Browning, Paul ^d   Goumon, Yannick ^e  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

^d LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^e Centre de Neurochimie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD16 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; KETAMINE; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; TRANSCRIPTION FACTOR AP 1;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRAIN HL 60; CELL STRAIN U937; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; LEUKOCYTE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 77949305993     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181c95cfa     Document Type: Article

References (52)

1. Weigand MA, Schmidt H, Zhao Q, Plaschke K, Martin E, Bardenheuer HJ. Ketamine modulates the stimulated adhesion molecule expression on human neutrophils in vitro. Anesth Analg 2000;90:206-212 (Pubitemid 30022997)
2. Krumholz W, Endrass J, Hempelmann G. Inhibition of phagocytosis and killing of bacteria by anaesthetic agents in vitro. Br J Anaesth 1995;75:66-70
3. Kawasaki T, Ogata M, Kawasaki C, Ogata J, Inoue Y, Shigematsu A. Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro. Anesth Analg 1999;89:665-669 (Pubitemid 29409817)
4. Yang J, Li W, Duan M, Zhou Z, Lin N, Wang Z, Sun J, Xu J. Large dose ketamine inhibits lipopolysaccharide-induced acute lung injury in rats. Inflamm Res 2005;54:133-137 (Pubitemid 40767561)
5. Helmer KS, Suliburk JW, Mercer DW. Ketamine-induced gastroprotection during endotoxemia: role of heme-oxygenase-1. Dig Dis Sci 2006;51:1571-1581
6. Suliburk JW, Helmer KS, Gonzalez EA, Robinson EK, Mercer DW. Ketamine attenuates liver injury attributed to endotoxemia: role of cyclooxygenase-2. Surgery 2005;138:134-140 (Pubitemid 41253793)
7. Sun J, Zhou ZQ, Lv R, Li WY, Xu JG. Ketamine inhibits LPS-induced calcium elevation and NF-kappa B activation in monocytes. Inflamm Res 2004;53:304-308 (Pubitemid 38969361)
8. Mazar J, Rogachev B, Shaked G, Ziv NY, Czeiger D, Chaimovitz C, Zlotnik M, Mukmenev I, Byk G, Douvdevani A. Involvement of adenosine in the antiinflammatory action of ketamine. Anesthesiology 2005;102:1174-1181 (Pubitemid 40745836)
9. Maekawa K, Futami S, Nishida M, Terada T, Inagawa H, Suzuki S, Ono K. Effects of trauma and sepsis on soluble L-selectin and cell surface expression of L-selectin and CD11b. J Trauma 1998;44:460-468 (Pubitemid 28153095)
10. Groeneveld PH, Kwappenberg KM, Langermans JA, Nibbering PH, Curtis L. Relation between pro- and anti-inflammatory cytokines and the production of nitric oxide (NO) in severe sepsis. Cytokine 1997;9:138-142 (Pubitemid 27116889)
11. Sun J, Li F, Chen J, Xu J. Effect of ketamine on NF-kappa B activity and TNF-alpha production in endotoxin-treated rats. Ann Clin Lab Sci 2004;34:181-186 (Pubitemid 38685912)
12. Blackwell TS, Christman JW. The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol 1997; 17:3-9 (Pubitemid 127500814)
13. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994;12:141-179 (Pubitemid 2081202)
14. Roebuck KA. Regulation of interleukin-8 gene expression. J Interferon Cytokine Res 1999;19:429-438
15. Mukaida N, Okamoto S, Ishikawa Y, Matsushima K. Molecular mechanism of interleukin-8 gene expression. J Leukoc Biol 1994;56:554-558 (Pubitemid 24348811)
16. Foletta VC, Segal DH, Cohen DR. Transcriptional regulation in the immune system: all roads lead to AP-I. J Leukoc Biol 1998;63:139-152
17. Heller A, Heller S, Blecken S, Urbaschek R, Koch T. Effects of intravenous anesthetics on bacterial elimination in human blood in vitro. Acta Anaesthesiol Scand 1998;42:518-526 (Pubitemid 28218472)
18. Nishina K, Akamatsu H, Mikawa K, Shiga M, Maekawa N, Obara H, Niwa Y. The inhibitory effects of thiopental, midazolam, and ketamine on human neutrophil functions. Anesth Analg 1998;86:159-165 (Pubitemid 28040111)
19. Domino EF, Zsigmond EK, Domino LE, Domino KE, Kothary SP, Domino SE. Plasma levels of ketamine and two of its metabolites in surgical patients using a gas chromatographic mass fragmentographic assay. Anesth Analg 1982;61:87-92
20. Schreiber E, Matthias P, Müller MM, Schaffner W. Rapid detection of octamer binding proteins with mini-extracts prepared from a small number of cells. Nucleic Acids Res 1989;17:6419 (Pubitemid 19198635)
21. Genever PG, Wilkinson DJ, Patton AJ, Peet NM, Hong Y, Mathur A, Erusalimsky JD, Skerry TM. Expression of a functional N-methyl-D-aspartate-type glutamate receptor by bone marrow megakaryocytes. Blood 1999;93:2876-2883 (Pubitemid 29200778)
22. Cadet P, Bilfinger TV, Fimiani C, Peter D, Stefano GB. Human vascular and cardiac endothelia express mu opiate receptor transcripts. Endothelium 2000;7:185-191 (Pubitemid 30406708)
23. Foulds S. Novel flow cytometric method for quantifying nuclear binding of the transcription factor nuclear factor kappa B in unseparated human monocytes and polymorphonuclear cells. Cytometry 1997;29:182-186 (Pubitemid 27444669)
24. Welters ID, Menzebach A, Goumon Y, Cadet P, Menges T, Hughes TK, Hempelmann G, Stefano GB. Morphine inhibits NF-kappaB nuclear binding in human neutrophils and monocytes by a nitric oxide dependent mechanism. Anesthesiology 2000;92:1677-1684 (Pubitemid 30412488)
25. Nair VD, Niznik HB, Mishra RK. Interaction of NMDA and dopamine D2L receptors in human neuroblastoma SH-SY5Y cells. J Neurochem 1996;66:2390-2393 (Pubitemid 26159073)
26. Gies EK, Peters DM, Gelb CR, Knag KM, Peterfreund RA. Regulation of mu opioid receptor mRNA levels by activation of protein kinase C in human SH-SY5Y neuroblastoma cells. Anesthesiology 1997;87:1127-1138 (Pubitemid 27469312)
27. Zahler S, Heindl B, Becker BF. Ketamine does not inhibit inflammatory responses of cultured human endothelial cells but reduces chemotactic activation of neutrophils. Acta Anaesthesiol Scand 1999;43:1011-1016 (Pubitemid 29529813)
28. Sun J, Wang XD, Liu H, Xu JG. Ketamine suppresses endotoxin-induced NF-kappaB activation and cytokines production in the intestine. Acta Anaesthesiol Scand 2004;48: 317-321 (Pubitemid 38295343)
29. Brown K, Park S, Kanno T, Franzoso G, Siebenlist U. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc Natl Acad Sci USA 1993; 90:2532-2536
30. Lentsch AB, Shanley TP, Sarma V, Ward PA. In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. J Clin Invest 1997;100: 2443-2448
31. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NFkappa B activity through induction of I kappa B synthesis. Science 1995;270:286-290
32. Oeth P, Mackman N. Salicylates inhibit lipopolysaccharideinduced transcriptional activation of the tissue factor gene in human monocytic cells. Blood 1995;86:4144-4152
33. Adams HA. Mechanisms of action of ketamine Anaesthesiol Reanim 1998;23:60-63
34. Hirota K, Okawa H, Appadu BL, Grandy DK, Devi LA, Lambert DG. Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells. Anesthesiology 1999;90:174-182
35. Nakao S, Miyamoto E, Masuzawa M, Kambara T, Shingu K. Ketamine-induced c-Fos expression in the mouse posterior cingulate and retrosplenial cortices is mediated not only via NMDA receptors but also via sigma receptors. Brain Res 2002;926:191-196 (Pubitemid 34117607)
36. Song C, Leonard BE. Comparison between the effects of sigma receptor ligand JO 1784 and neuropeptide Y on immune functions. Eur J Pharmacol 1998;345:79-87 (Pubitemid 28179474)
37. Haeseler G, Tetzlaff D, Bufler J, Dengler R, Munte S, Hecker H, Leuwer M. Blockade of voltage-operated neuronal and skeletal muscle sodium channels by S(+)- and R(-)-ketamine. Anesth Analg 2003;96:1019-1026 (Pubitemid 36359035)
38. Hijazi Y, Boulieu R. Protein binding of ketamine and its active metabolites to human serum. Eur J Clin Pharmacol 2002; 58:37-40 (Pubitemid 34327991)
39. Wu GJ, Chen TL, Ueng YF, Chen RM Ketamine inhibits tumor necrosis factor-alpha and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation. Toxicol Appl Pharmacol 2008;228:105-113
40. Chang Y, Chen TL, Sheu JR, Chen RM. Suppressive effects of ketamine on macrophage functions. Toxicol Appl Pharmacol 2005;204:27-35 (Pubitemid 40387564)
41. Brookes ZL, Reilly CS, Lawton BK, Brown NJ. Intravenous anesthesia inhibits leukocyte-endothelial interactions and expression of CD11b after hemorrhage. Shock 2006;25:492-499
42. Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, Matsushima K. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 1994;56:559-564 (Pubitemid 24348812)
43. Friedland JS, Suputtamongkol Y, Remick DG, Chaowagul W, Strieter RM, Kunkel SL, White NJ, Griffin GE. Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection. Infect Immun 1992;60:2402-2408
44. Yu M, Shao D, Yang R, Feng X, Zhu S, Xu J. Effects of ketamine on pulmonary inflammatory responses and survival in rats exposed to polymicrobial sepsis. J Pharm Pharm Sci 2007; 10:434-442
45. Song XM, Li JG, Wang YL, Zhou Q, Du ZH, Jia BH, Ke JJ. Effects of ketamine on proinflammatory cytokines and nuclear factor kappaB in polymicrobial sepsis rats. World J Gastroenterol 2006;12:7350-7354 (Pubitemid 44911846)
46. Gurfinkel R, Czeiger D, Douvdevani A, Shapira Y, Artru AA, Sufaro Y, Mazar J, Shaked G. Ketamine improves survival in burn injury followed by sepsis in rats. Anesth Analg 2006;103:396-402, table of contents (Pubitemid 44140641)
47. Shaked G, Czeiger D, Dukhno O, Levy I, Artru AA, Shapira Y, Douvdevani A. Ketamine improves survival and suppresses IL-6 and TNFalpha production in a model of Gram-negative bacterial sepsis in rats. Resuscitation 2004;62:237-242 (Pubitemid 39037266)
48. Taniguchi T, Takemoto Y, Kanakura H, Kidani Y, Yamamoto K. The dose-related effects of ketamine on mortality and cytokine responses to endotoxin-induced shock in rats. Anesth Analg 2003;97:1769-1772 (Pubitemid 37475136)
49. Taniguchi T, Shibata K, Yamamoto K. Ketamine inhibits endotoxin-induced shock in rats. Anesthesiology 2001;95: 928-932 (Pubitemid 32939117)
50. DeClue AE, Cohn LA, Lechner ES, Bryan ME, Dodam JR. Effects of subanesthetic doses of ketamine on hemodynamic and immunologic variables in dogs with experimentally induced endotoxemia. Am J Vet Res 2008;69:228-232
51. Taniguchi T, Kanakura H, Takemoto Y, Yamamoto K. The antiinflammatory effects of ketamine in endotoxemic rats during moderate and mild hypothermia. Anesth Analg 2004; 98:1114-1120 (Pubitemid 38405431)
52. Kawasaki C, Kawasaki T, Ogata M, Nandate K, Shigematsu A. Ketamine isomers suppress superantigen-induced proinflammatory cytokine production in human whole blood. Can J Anaesth 2001;48:819-823 (Pubitemid 33040242)